LAUSR

The dietary effect of fructooligosaccharide (FOS) supplementation as an alternative to antibiotics on ileal mucosa and digesta microbiota was investigated in broiler chickens (n = 180). The study included three dietary treatments from d1 to 21: 1) positive control (PC), a wheat-corn-soybean meal based diet containing antibiotics (virginiamycin and monensin); 2) negative control (NC), as wheat-corn-soybean meal based diet without antibiotics; and 3) NC + FOS, as NC diet supplemented 0.5% of FOS. Ileal mucosa and digesta were collected and subjected to 16S rRNA-based next generation sequencing. No significant difference on α-, ß-diversity and bacterial phyla was observed between ileal mucosa and digesta or between the three dietary treatments. Partial least square discriminant analysis and Venn analysis showed that different bacterial genera were associated with different ileal sites or diets. A distinct distance on ileal mucosa bacteria communities were observed between PC and NC + FOS dietary treatments. FOS supplementation increased the number of unique genera and resulted in a more diverse microbiota in the ileal mucosa when compared with PC and NC groups. Furthermore, microorganisms that have pathogenic properties such as Helicobacter and Desulfovibrio were found significantly reduced when compared between NC and NC + FOS groups in the ileal mucosa. Lachnospiraceae (f) was greater in the ileal mucosa than that in the digesta, particularly among the NC + FOS dietary group. Overall, supplementing FOS in broiler chicken diets may be able to modulate gut microbiota in favor of chicken health, which in turn, can be used as an alternative method to replace antibiotic growth promoters (AGPs). Future investigation on the mechanism of FOS and other prebiotic products as dietary supplements is warranted.